Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.

2026
https://researcherprofiles.org/profile/786516631
42241705
Sheth S, Lal A, Appiah-Kubi A, Peslak SA, Toiber Temin N, Chen MA, Coates TD